Company intelligence / Profile preview

Jaén

South San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Jaen Therapeutics is a stealth-stage biotechnology company focused on the discovery and development of novel small molecule therapeutics for the treatment of cancer. Founded by Juan Jaen, a veteran drug hunter and co-founder of Arcus Biosciences and ChemoCentryx, the company leverages deep expertise in medicinal chemistry and immunology to target high-value biological pathways. While specific programs remain undisclosed, the firm is positioned to address significant unmet needs in oncology through innovative drug design. Jaen Therapeutics operates out of the San Francisco Bay Area and is backed by prominent life science venture capital investors.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Jaén.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jaén.

Explore the full profile